IDEXX LABORATORIES INC /DE (IDXX)
IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test
IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test
CalciMedica Reports Second Quarter 2026 Financial Results and Provides Clinical & Corporate Updates
Beamr Issues Q2-2026 CEO Letter to Shareholders: Expanding Our Reach into Autonomous Vehicle Teams
Bioxytran Reports Encouraging Clinical Observations in First Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Patient Treated with PLICID, a Novel Galectin Antagonist Designed with Artificial Intelligence
Gain Therapeutics Reports Financial Results for Second Quarter 2026 and Provides Corporate Update
Terrestrial Energy Reports Second Quarter 2026 Results
Philadelphia Cream Cheese and Ziggis Coffee Reimagine a Beloved Breakfast Duo with First-Ever Philadelphia Everything Bagel Latte
Xtant Medical Reports Second Quarter 2026 Financial Results
Beyond Meat Announces 1-for-30 Reverse Stock Split
TRF-1 mantém decisões favoráveis ao Projeto Potássio Autazes e impede o encaminhamento de recursos aos tribunais superiores do Brasil